Lakcid Gastromed

Lactobacillus rhamnosus, the active ingredient in Lakcid Gastromed, is a probiotic presented as an oral formulation for oral use. It supports gastrointestinal health by helping maintain a balanced intestinal microbiota. GNH USA supplies Lakcid Gastromed as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Lakcid Gastromed, a probiotic, acts on the gastrointestinal microbiome to promote gut balance. - Antibiotic‑associated diarrhea: helps reduce the incidence and duration of diarrhea during or after antibiotic therapy. - Irritable bowel syndrome: may alleviate abdominal discomfort and irregular bowel movements. - Traveler's diarrhea: supports the gut flora to lessen the risk of diarrhea during travel.

Probiotic supplementation is generally well tolerated, but some individuals may experience mild reactions.

Common Side Effects: - Bloating: mild abdominal distension. - Flatulence: increased gas production. - Mild abdominal cramps: transient discomfort. - Nausea: occasional feeling of queasiness. - Diarrhea: rare, self‑limiting loose stools.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Sepsis: extremely rare bloodstream infection, primarily in severely immunocompromised patients. - Fungal overgrowth: opportunistic candidiasis in vulnerable individuals. - Persistent fever: may indicate systemic infection. - Severe abdominal pain: warrants medical evaluation.

Before using Lakcid Gastromed, consider the following safety measures. - Medical supervision: consult a healthcare professional, especially for chronic conditions. - Immunocompromised patients: use only under physician guidance due to infection risk. - Severe illness: avoid if experiencing acute gastrointestinal infection. - Pregnancy and breastfeeding: discuss with a doctor before use. - Children: dosage and suitability should be determined by a pediatrician. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lactobacillus rhamnosus may interact with certain medications, affecting efficacy or safety.

Major Interactions (Avoid): - Antibiotics: concurrent use can reduce probiotic viability; separate administration by at least 2 hours. - Antifungal agents: may diminish probiotic colonization.

Moderate Interactions (Monitor Closely): - Immunosuppressants: monitor for signs of infection. - Proton pump inhibitors: may alter gastric pH, affecting probiotic survival. - Chemotherapy agents: assess risk of translocation in neutropenic patients.